Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesBeginning Cash BalanceBeginning Cash BalanceCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Summit Therapeutics (SMMT) Gains from Investment Securities (2020 - 2025)

Summit Therapeutics' Gains from Investment Securities history spans 6 years, with the latest figure at $12.5 million for Q4 2025.

  • For Q4 2025, Gains from Investment Securities changed N/A year-over-year to $12.5 million; the TTM value through Dec 2025 reached $17.1 million, up 304.55%, while the annual FY2025 figure was $17.1 million, 304.55% up from the prior year.
  • Gains from Investment Securities reached $12.5 million in Q4 2025 per SMMT's latest filing, up from $856000.0 in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $12.5 million in Q4 2025 to a low of -$4.2 million in Q4 2023.
  • Average Gains from Investment Securities over 5 years is $2.0 million, with a median of $970500.0 recorded in 2021.
  • Peak YoY movement for Gains from Investment Securities: plummeted 36266.67% in 2021, then soared 91700.0% in 2025.
  • A 5-year view of Gains from Investment Securities shows it stood at -$307000.0 in 2021, then soared by 997.72% to $2.8 million in 2022, then plummeted by 252.14% to -$4.2 million in 2023, then skyrocketed by 258.79% to $6.7 million in 2024, then soared by 88.16% to $12.5 million in 2025.
  • Per Business Quant, the three most recent readings for SMMT's Gains from Investment Securities are $12.5 million (Q4 2025), $856000.0 (Q3 2025), and $3.7 million (Q2 2025).